The impact of portal vein major circulation short-circuit embolization on the clinical course of the disease.

The impact of portal vein major circulation short-circuit embolization on the clinical course of the disease. - The impact of portal vein major circulation short-circuit embolization on the clinical course of the disease.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000052853

Enrollment

1000

Registered

2023-11-21

Start date

2023-08-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diffuse liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet all of the following conditions are eligible (1) Patients with diffuse liver disease

Exclusion criteria

Exclusion criteria: Patients who meet any of the following conditions are not eligible 1) Patients who are deemed by the investigator or subinvestigator to be unsuitable for the safe conduct of this study. 2) Patients who have expressed their refusal to participate in this study through a disclosure document. 3) Any other cases in which the safety of the patient may be compromised in the conduct of this study or in which it is deemed difficult to comply with the study protocol.

Design outcomes

Primary

Measure	Time frame
Comparison of overall survival within the study period with and without BRTO	—

Countries

Japan

Contacts

Public ContactHidemi Unozawa

Chiba University Hospital Gastroenterology

unozawa.hidemi@chiba-u.jp43222717

Outcome results